BLCO
Bausch + Lomb Corp.
NYSE · Healthcare · Medical - Instruments & Supplies · CA
$20.68
+3.25%Next report
Analyst consensus
- Next report date
- Feb 17, 2027
- EPS estimate
- $0.34
- Revenue estimate
- $1.5B
Latest reported
- Last report date
- Oct 28, 2026
- EPS actual
- $0.34
- EPS estimate
- $0.21
- Revenue actual
- $1.4B
- Revenue estimate
- $1.4B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +21.7%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $22
- PT range
- $19 – $24
- Analysts
- 8
4 Buy4 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 28, 2026 | $0.21 | $0.34 | Beat 58.51% | $1.4B |
| Jul 29, 2026 | $0.15 | $0.16 | Beat 3.63% | $1.4B |
| Apr 29, 2026 | $0.06 | $0.08 | Beat 33.33% | $1.2B |
| Feb 18, 2026 | $0.35 | $0.32 | Miss -8.57% | $1.4B |
| Oct 29, 2025 | $0.16 | $0.18 | Beat 12.50% | $1.3B |
| Jul 30, 2025 | $0.06 | $0.07 | Beat 16.67% | $1.3B |
| Apr 30, 2025 | $0.03 | -$0.07 | Miss -325.81% | $1.1B |
| Feb 19, 2025 | $0.24 | $0.25 | Beat 4.60% | $1.3B |
| Oct 30, 2024 | $0.16 | $0.17 | Beat 6.25% | $1.2B |
| Jul 31, 2024 | $0.13 | $0.13 | In line | $1.2B |
| May 1, 2024 | $0.09 | $0.07 | Miss -22.22% | $1.1B |
| Feb 21, 2024 | $0.17 | $0.24 | Beat 41.18% | $1.2B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 17, 2027